Scarica l'app Stockscreener
1.25
3.85%
-0.05
Dopo l'orario di chiusura:
1.27
0.02
+1.60%
Precedente Chiudi:
$1.30
Aprire:
$1.3
Volume 24 ore:
315.89K
Relative Volume:
1.04
Capitalizzazione di mercato:
$22.50M
Reddito:
-
Utile/perdita netta:
$-8.29M
Rapporto P/E:
-1.7857
EPS:
-0.7
Flusso di cassa netto:
$-6.47M
1 W Prestazione:
+1.63%
1M Prestazione:
-16.67%
6M Prestazione:
-17.22%
1 anno Prestazione:
-14.97%
Intervallo 1D:
$1.25
$1.30
Intervallo di 1 settimana:
$1.23
$1.49
Portata 52W:
$0.94
$2.2299
NanoViricides Inc Stock (NNVC) Company Profile
Nome
NanoViricides Inc
Settore
Industria
Telefono
203-937-6137
Indirizzo
1 Controls Drive, Shelton, CT
Confronta NNVC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.25 | 23.40M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2015-02-11 | Iniziato | Midtown Partners | Strong Buy |
NanoViricides Inc Borsa (NNVC) Ultime notizie
In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides - SouthCoastToday.com
NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo - Amarillo Globe-News
NanoViricides Dual Track Clinical Strategy Explained by a Research ReportBroad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute Respiratory Infections of All Viruses - Daytona Beach News-Journal
Belarus frees Nobel laureate Ales Bialiatksi and opposition figure Maria Kolesnikova from prison, rights group confirms - Barchart.com
Applied Digital, Benchmark, Knowles, Cognex, and Flex Stocks Trade Down, What You Need To Know - Barchart.com
Shootin' the Bull about wait and see - Barchart.com
2 Small-Cap Biotechs That Could Reward Patient Investors - Investing.com
EU indefinitely freezes Russian assets to stop Moscow-friendly Hungary and Slovakia from vetoing their use for Ukraine - Barchart.com
2 Small-Cap Biotechs That Could Reward Patient Investors - MarketBeat
Is Clorox Stock Underperforming the S&P 500? - Barchart.com
Is J.B. Hunt Transport Services Stock Outperforming the Dow? - Barchart.com
Americans, including many in Trump’s base, overwhelmingly see higher holiday prices than normal, an AP-NORC poll finds - Barchart.com
Is Hologic Stock Outperforming the Nasdaq? - Barchart.com
How Is VeriSign’s Stock Performance Compared to Other Software Stocks? - Barchart.com
NanoViricides Holds 2025 Annual Stockholders Meeting - MSN
US sanctions 3 nephews of Venezuelan President Maduro as Trump further ramps up pressure on South American nation - Barchart.com
This AI Stock Has 45% Upside Potential and No One Is Talking About It Yet - Barchart.com
How Is Best Buy's Stock Performance Compared to Other Specialty Retail Stocks? - Barchart.com
Corpay Stock: Is CPAY Underperforming the Technology Sector? - Barchart.com
3 Reasons EYE is Risky and 1 Stock to Buy Instead - Barchart.com
Omnicom Group (OMC) Stock Is Up, What You Need To Know - Barchart.com
Is Veralto Corporation Stock Underperforming the S&P 500? - Barchart.com
Is Steel Dynamics Stock Outperforming the Dow? - Barchart.com
Is PTC Stock Underperforming the Nasdaq? - Barchart.com
Is Invitation Homes Stock Underperforming the Dow? - Barchart.com
Is Teradyne Stock Outperforming the Nasdaq? - Barchart.com
Is Cardinal Health Stock Outperforming the Nasdaq? - Barchart.com
Chewy (NYSE:CHWY) Surprises With Q3 CY2025 Sales - Barchart.com
Is FirstEnergy Stock Underperforming the S&P 500? - Barchart.com
How Is Rollins’ Stock Performance Compared to Other Cyclical Stocks? - Barchart.com
GBPUSD Extends Rally As Bullish Impulse Builds - Barchart.com
3 Inflated Consumer Stocks That Concern Us - Barchart.com
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive - Savannah Morning News
Apple Stock Marks a Solid Comeback. Is AAPL a Buy, Sell, or Hold for 2026? - Barchart.com
Marvell Soars 32% in 3 Months — Is MRVL Stock a Buy, Sell, or Hold? - Barchart.com
AeroVironment: Fiscal Q2 Earnings Snapshot - Barchart.com
NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles - Enterprise News
Why Are Revolve (RVLV) Shares Soaring Today - Barchart.com
Upwork (UPWK) Stock Is Up, What You Need To Know - Barchart.com
Why Flex (FLEX) Stock Is Up Today - Barchart.com
This Clinical-Stage Biotech Just Raised $6M to Advance a Drug That Could Address Pandemic Preparedness Gaps - Barchart.com
DiagnosTear Technologies Inc.Confirmation of No Material Change - Barchart.com
A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricidesNV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus - York Dispatch
Stocks in play: Parex Resources Inc. - Barchart.com
NanoViricides Inc Stock Analysis and ForecastGlobal Trade Effects & Free Get Breakthrough Ideas - earlytimes.in
Upstart (UPST): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
Oracle Earnings: What To Look For From ORCL - Barchart.com
Strategy Inc. Buys 10,624 More Bitcoin, Lifts Holdings to 660,624 BTC - Barchart.com
Stocks in play: Aurora Cannabis Inc. - Barchart.com
Is L3Harris Technologies Stock Underperforming the Nasdaq? - Barchart.com
EURNZD May Have Topped - Barchart.com
NanoViricides Inc Azioni (NNVC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):